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derived from the biosynthetic pathways resulting in the 
conversion of essential precursors to their respective elon-
gated polyenoic products. 
 The availability of PUFA in mammalian cells greatly de-
pends on the activity of enzymes involved in FA metabo-
lism. In animals and humans, the   5- and   6-desaturases 
are the pivotal enzymes introducing de novo unsaturations 
in the carbon chain of precursors leading to the synthesis 
of long-chain PUFA (LC-PUFA). These enzymes were 
cloned 10 years ago from mammals ( 2–5 ). In parallel, 
Marquardt et al. ( 6 ) described the human genomic struc-
ture of the fatty acid desaturase ( FADS ) cluster including 
the  FADS1 and  FADS2 genes coding, respectively, for the 
  5- and   6-desaturases. A third gene, named  FADS3 , was 
identifi ed, revealing 62% and 70% nucleotide sequence 
identity with  FADS1 and  FADS2 , respectively. Further stud-
ies showed a signifi cant correlation between  FADS3 poly-
morphism and lipid metabolism markers such as PUFA, 
high density- or low density-lipoprotein cholesterol, and 
triglyceride levels ( 7–10 ). The newly discovered gene was 
thereafter integrated into a serial analysis of gene expres-
sion and a DNA microarray succeeding in more physiolog-
ical data.  FADS3 was therefore found to be highly expressed 
at the implantation site of the embryo in mouse uterus 
( 11 ) and downregulated during human neurogenic differ-
entiation ( 12 ). More recently, Park et al. described, in ba-
boon, different alternative transcripts of  FADS3 generated 
by alternative splicing, which suggests the occurrence of 
multiple  FADS3 gene products ( 13 ). This study also showed 
a different pattern of expression in response to human 
neuroblastoma SK-N-SH cell differentiation. All data to-
gether only concern the  FADS3 gene with no description 
of the functional role of the putative FADS3 protein. 
 Abstract  In 2000, Marquardt et al. (A. Marquardt, H. Stöhr, 
K. White, and B. H. F. Weber. 2000. cDNA cloning, genomic 
structure, and chromosomal localization of three members 
of the human fatty acid desaturase family.  Genomics . 66: 
176–183.)  described the genomic structure of the fatty acid 
desaturase ( FADS ) cluster in humans. This cluster includes 
the  FADS1 and  FADS2 genes encoding, respectively, for the 
  5- and   6-desaturases involved in polyunsaturated fatty 
acid biosynthesis. A third gene, named  FADS3 , has recently 
been identifi ed but no functional role has yet been attrib-
uted to the putative FADS3 protein. In this study, we investi-
gated the FADS3 occurrence in rat tissues by using two 
specifi c polyclonal antibodies directed against the N-terminal 
and C-terminal ends of rat FADS3. Our results showed three 
potential protein isoforms of FADS3 (75 kDa, 51 kDa, and 
37 kDa) present in a tissue-dependent manner. The occur-
rence of these FADS3 isoforms did not depend on the 
mRNA level determined by real-time PCR. In parallel, 
mouse tissues were also tested and showed the same three 
FADS3 isoforms but with a different tissue distribution. Fi-
nally, we reported the existence of FADS3 in human cells 
and tissues but different new isoforms were identifi ed.  To 
conclude, we showed in this study that FADS3 does exist 
under multiple protein isoforms depending on the mamma-
lian tissues. These results will help further investigations to 
determine the physiological function of FADS3. —Pédrono, 
F., H. Blanchard, M. Kloareg, S. D’andréa, S. Daval, V. Rioux, 
and P. Legrand.  The fatty acid desaturase 3 gene encodes 
for different FADS3 protein isoforms in mammalian tissues. 
 J. Lipid Res . 2010.  51: 472–479. 
 Supplementary key words protein isoform • mRNA level • rat • 
human 
 PUFAs are key components involved in a variety of phys-
iological functions ( 1 ). Some of them, belonging to the 
n-6 or n-3 families, have to be fulfi lled from the diet or 
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the putative involvement of  Fads3 in the FA metabolism. 
No biological assignment has yet been attributed to that 
latest gene; no evidence has emerged concerning the 
translation from the transcript into the protein. Thus, the 
question is, does the FADS3 protein exist? To answer this 
query, we reported in this study the expression of  Fads3 in 
mammalian tissues. We fi rst analyzed the transcript level 
of  Fads3 in rat tissues and then we investigated the occur-
rence of the FADS3 protein in mammalian cells or 
tissues. 
 MATERIALS AND METHODS 
 Materials 
 DMEM and antibiotics were purchased from Eurobio (Les 
Ulis, France). Fetal calf serum (FCS) was obtained from Lonza 
(Levallois-Perret, France). African green monkey kidney Cos-7 
cell lines (from ECACC), HRP conjugated mouse anti-IgG, mouse 
 A protein database search identifi ed FADS3 as a front 
end desaturase as well as FADS1 and FADS2. The pre-
dicted structure of FADS3 describes a membrane-bound 
desaturase composed of an N-terminal cytochrome b5-like 
domain and a C-terminal FA desaturase domain ( Fig. 1A ). 
 These two domains are thought to be potentially involved 
in the regulation or the catalytic assignment of the desatu-
rase as previously reported for FADS2 ( 14 ), suggesting an 
FA desaturase role of FADS3. It is therefore possible to as-
sume that FADS3 exists in cells. 
 A recent study reported an enhanced mRNA expression 
of  Fads3 in liver of  Fads2   /   mice ( 15 ). Deletion of the 
 Fads2 gene modifi es the enzymatic pathways of LC-PUFA 
biosynthesis without impairing the normal lifespan of 
 Fads2   /   mice but causing a variety of pathologies ( 16 ). 
FADS2 is known to catalyze the conversion of multiple FA 
substrates ( 17–19 ) and thus, to take part in many physio-
logical functions. The close relationship between  Fads2 
and  Fads3 in these knockout mice is thought to underline 
 Fig.  1. Structure of the putative rat FADS3 protein and peptides designed to produce specifi c rat FADS3 
antibodies. A: Rat FADS3 displays an FA membrane-bound desaturase structure with two distinct domains. In 
the N-terminal end, the cytochrome b5-like domain is specifi c of front-end desaturases, introducing a dou-
ble bond before the eighth carbon of the FA carbon chain; the HPGG motif present in that domain is a 
pivotal pattern for the desaturase activity. In the carboxyl-terminal end, the FA desaturase domain is charac-
terized by three histidine boxes necessary for the catalysis; in the third box, the fi rst amino acid is a glu-
tamine (Q) instead of a histidine (H), which is characteristic of the front-end desaturases such as   5-,   6-, 
and   8-desaturases, as compared with the methyl-end desaturases like   12- and   15-desaturases. B: Different 
antibodies were produced to detect FADS3 in rat tissues. Several peptides were, thus, designed according to 
the putative sequence of rat FADS3. Among the eight generated antibodies, only three recognized FADS3. 
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GGC GT-3 ′ ) including the candidate translation start codon (in 
bold) and a  NcoI restriction site (underlined) and the cloning 
reverse primer (5 ′ -ACT  GCG GCC GC C T TC A CT GAT GGA 
GGT ACG C-3 ′ ) with the putative stop codon (in bold) and a  NotI 
restriction site (underlined). The resulting 1350-bp PCR product 
was cloned into a pCMV/ myc / cyto expression vector and the in-
frame orientation was confi rmed by DNA sequencing. The re-
combinant plasmid is referred to as pCMV/ Fads3 . The sequence 
of the full-length rat  Fads3 cDNA is available in the GenBank da-
tabase (accession number AJ494720). 
 Plasmid transfection 
 Rat recombinant FADS1, FADS2, and FADS3 were expressed 
after transfection of pCMV/ myc / cyto plasmids containing the 
rat  Fads1 (pCMV/ Fads1 ),  Fads2 (pCMV/ Fads2 ), or  Fads3 
(pCMV/ Fads3 ) gene inserts ( 17 ). Recombinant plasmids were 
transiently transfected into Cos-7 cells using electroporation. 
Briefl y, 70% confl uent cells were electroporated (250V-1500µF) 
and then cultured in DMEM with 10% FCS. After 48 h, cells were 
scraped off and protein extracts were diluted in RIPA buffer. The 
transfection effi ciency was assessed by   -galactosidase colorimet-
ric assay after cotransfection with pCMV•SPORT-  gal. 
 Quantifi cation of the  Fads mRNA level by real-time PCR 
 Total RNA was extracted from the tissues of three rats with 
Extract-All ® (Eurobio, Les Ulis, France) and retrotranscripted in 
duplicates using SuperScript TM II reverse transcriptase (Invitro-
gen, Cergy Pontoise, France) according to the manufacturer’s 
instructions. Real-time PCR was performed in duplicates with the 
TaqMan Universal PCR Master Mix (Applied Biosystems, Courta-
boeuf, France) containing 40 ng of retrotranscripted RNA, 0.5 
µM of each primer, and 0.25 µM of TaqMan probe ( Table 1 ). 
PCR was run using ABI Prism 7000 sequence detection system 
(Applied Biosystems, Courtaboeuf, France) as follows: 2 min at 
50°C, 5 min at 95°C, 40 cycles of 10 s at 95°C, and 1 min at 60°C 
(SENAH, INRA, Saint-Gilles, France). Normalization was assessed 
using the Yakima Yellow ® -Eclipse ® DarkQuencher 18S rRNA con-
trol kit (Eurogentec, Angers, France). The PCR effi ciency was 
estimated by calibration curves and by calculation using LinReg 
( 20 ). The relative expression was evaluated as delta Cycle thresh-
old (  Ct = Ct fads   Ct 18S ). 
 Rat FADS3 antibody production 
 Two polyclonal antibodies against  Rattus norvegicus FADS3 
were produced using a double-X 28-day protocol (Eurogentec, 
Angers, France). Briefl y, two specifi c peptides corresponding 
to the N-terminal sequence ( 31 QIRQHDLPGDKWL) and the 
carboxyl-terminal sequence ( 352 PKEIGHEKHRDWAS) of rat FADS3 
( Fig. 1B ) were synthesized and coupled to Keyhole Limpet He-
mocyanin; these target peptides display 85% and 100% identity 
with the human protein sequence respectively. Rabbits were then 
coimmunized with both peptides for 4 weeks. The two antibodies 
were then purifi ed from the serum by affi nity chromatography 
and were respectively referred to as anti-NtermFADS3 and anti-
CtermFADS3. The specifi c reactivity of each antibody was checked 
by blot against the immunizing peptides and by Western blot 
against recombinant FADS3. A third antibody, referred to as anti-
FADS2/3, was also punctually used because of its immunospeci-
fi city with rat recombinant FADS2 and FADS3. This third 
nonpurifi ed polyclonal serum was produced by immunization of 
rabbits with two peptides as described in  Fig. 1B ( 17 ). 
 Protein expression 
 Protein expression was assessed by Western blot after SDS-
PAGE or native PAGE as described elsewhere ( 21 ). Rat FADS3 
monoclonal anti-GAPDH antibody, and chemicals were provided 
by Sigma-Aldrich (Saint-Quentin Fallavier, France). Chemicals 
for PCR were from Eurogentec (Angers, France). pCMV/ myc / cyto 
and pCMV•SPORT-  gal plasmids were from Invitrogen (Cergy 
Pontoise, France). Gene Pulser Xcell TM electroporation system 
and Kaleidoscope prestained standard were purchased from Bio-
Rad (Marnes-la-Coquette, France). Customized human normal 
tissue blot was from Interchim (Montluçon, France). HRP conju-
gated rabbit anti-IgG antibody and Immobilon detection kit were 
from Millipore (Guyancourt, France). Human neuroblastoma 
SH-SY5Y cells were kindly given by J. M. Alessandri (INRA, Jouy-en-
Josas, France). HUH7 cells were a generous gift from the Labora-
tory of Genetics (Agrocampus Ouest, Rennes, France). BALB/c 
female mouse tissues were kindly given by V. Le Moigne (Agro-
campus Ouest, Rennes, France). 
 Animals 
 Male and female Sprague-Dawley rats (150–200g body weight) 
were obtained from the Elevage Janvier breeding center (Le Gen-
est Saint Isle, France). Animals had access to standard rodent 
chow (Scientifi c Animal Food and Engineering, Augy, France) 
and water ad libitum. Rats were fasted 24 h before euthanasia and 
bled by decapitation after anesthesia and analgesia using intra-
peritoneal injection of pentothal (75 mg/kg body weight). Fresh 
tissues were used to extract RNA and proteins. White adipose tis-
sue (AT) was perirenal, intestine was from jejunum, and skeletal 
muscle corresponded to the thigh dorsal muscles. The experimen-
tal procedure was in compliance with recommendations of the 
2003/65/CEE European directive for animal experimentation. 
 Cell culture 
 Cos-7, SH-SY5Y, and HUH7 cell lines were cultured in DMEM 
supplemented with 10% FCS and complemented with antibiotics 
(50 UI/ml penicillin, 50 µg/ml streptomycin, 10µg/ml gentamy-
cin). Cells were maintained at 37°C in a humidifi ed atmosphere 
of air (95%) and CO 2 (5%) up to 70–80% confl uence. Cell ex-
tracts were prepared in radio immuno precipitation assay (RIPA) 
buffer containing PBS (150 mM NaCl, 0.95 mM NaH 2 PO 4 , 4.05 
mM Na 2 HPO 4 ; pH7.4), 1% Nonidet P40, 0.5% sodium deoxy-
cholate, 0.1% SDS, 1 mM EDTA, and 10 mg/ml aprotinin. Sam-
ples were also diluted in native lysis buffer (50 mM Tris-HCl pH8, 
1% Nonidet P40, 150 mM NaCl) when loading in native PAGE. 
 Rat  Fads3 cloning and plasmid construction 
 The human  FADS3 nucleotide sequence (GenBank accession 
number AF084560) was used to blast-search the rat genomic da-
tabase ( 6 ). Designed from the  Rattus norvegicus chromosome 1 
genomic contig NW_047563.2, an oligonucleotide primer 
(5 ′ -CAG CAA CGA AGA GGA GCA GTG TCC CAG TGG CA-3 ′ ) 
was produced to screen the rat liver Marathon-ready cDNA li-
brary by Rapid Amplifi cation cDNA Ends (RACE) reactions us-
ing the advantage-GC 2 PCR kit (Clontech, Saint-Germain-en-Laye, 
France). The 5 ′ end of the rat  Fads3 cDNA containing a candidate 
ATG start codon was obtained, as verifi ed by the sequencing of 
the resulting PCR product (SCRIBE, Rennes, France). Oligonucle-
otide primers were then designed to PCR amplify the full-length 
rat  Fads3 coding sequence from the rat liver Marathon-ready 
cDNA library. The forward primer (5 ′ -CAT CTC TCA GAC CTC 
TGC CAC GTA-3 ′ ) was deduced from the former 5 ′ end se-
quence. The reverse primer (5 ′ -CTG GGA AGA CAT GCT ATG 
CTC ACC-3 ′ ) was designed from a rat EST sequence (GenBank 
accession number AI178762) presenting a high sequence homol-
ogy with the human  FADS3 3 ′ fl anking region. After the fi rst-
round PCR, a nested PCR amplifi cation was performed using the 
cloning forward primer (5 ′ -TTG TGC ATA GCG G CC  ATG GG C 
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 Immunospecifi city of anti-NtermFADS3 and 
anti-CtermFADS3 antibodies 
 In order to assess the occurrence of FADS3 in rat tissues, 
we produced antibodies specifi cally targeted against rat 
FADS3. Different peptides were thus designed as described 
in  Fig. 1B . The fi rst successful antibody was produced after 
rabbit immunization with two long peptides. This poly-
clonal antibody was tested on rat recombinant FADS1, 
FADS2, and FADS3. Our results showed that this antibody 
recognized a protein at 48 kDa corresponding to recombi-
nant FADS3, but also a protein corresponding to recombi-
nant FADS2 at 45 kDa ( Fig. 3 ). This antibody was named 
anti-FADS2/3. Therefore, the nonspecifi city toward FADS3 
resulted in the production of new antibodies targeted 
against smaller peptides ( Fig. 1B ). Of seven antibodies, 
only two were successfully produced. The specifi city of an-
tibodies was tested on recombinant FADS1, FADS2, and 
FADS3 ( Fig. 3 ). Our results showed that both antibodies 
detected FADS3 but neither FADS1 nor FADS2. Thus, the 
antibody directed against the N-terminal end of FADS3 
was named anti-NtermFADS3 and the other one targeted 
toward the carboxyl-terminal end of FADS3 was named 
anti-CtermFADS3. 
 Identifi cation of the FADS3 protein in rat tissues 
 We then investigated the protein level of FADS3 in the 
same selected tissues as previously described for the mRNA 
level in rat tissues using the two FADS3 antibodies, anti-
NtermFADS3 and anti-CtermFADS3 ( Fig. 4 ) . The pre-
dicted molecular mass of rat FADS3 is 51.5 kDa according 
to the cDNA sequence. Our results showed a band around 
51 kDa essentially found in the liver and kidney and to a 
lesser extent in the heart and brown and white AT ( Fig. 
4A ). This 51 kDa band was also present in a few other tis-
sues but more than 40 µg of protein extracts were needed 
to visualize it by Western blot (data not shown). A similar 
result was obtained with the anti-NtermFADS3 antibody 
but the 51 kDa protein was also identifi ed by the anti-
CtermFADS3 antibody. Different bands were also observed 
at around 75 kDa and 37 kDa depending on the antibody. 
The anti-NtermFADS3 antibody recognized a 75 kDa pro-
tein in several organs, especially in the lung but also in the 
spleen, thymus, and aorta. The anti-CtermFADS3 antibody 
revealed a 37 kDa protein, highly abundant in skeletal and 
abdominal muscles, abundant in the brain and minor in 
the heart, eye, and thymus. Another band was also found 
below 37 kDa, for example, in the lung, stomach, and liver. 
This band may also be suspected in muscles under the ex-
tended signal as observed in diluted samples (data not 
shown). These data were representative for male rats but 
similar results were also obtained in females (data not 
antibodies were incubated at 4°C overnight at 1 µg/ml in tris-
buffered saline (20 mM Tris-HCl, 150 mM NaCl; pH7.4) contain-
ing 0.05% Tween-20 and 5% BSA. The other antibodies were 
used according to the manufacturer’s instructions. Primary anti-
bodies were then coupled to HRP conjugated anti-IgG and per-
oxidase activity was determined by chemoluminescent detection 
using Immobilon reagents. The protein level was estimated using 
anti-actin and confi rmed with anti-GAPDH. Actin was not de-
tected in the rat pancreas, nor was GAPDH detected in the rat 
intestine, so in this case results exhibit only one antibody to eval-
uate the tissue protein level. The molecular mass of proteins 
migrating in the gel was determined using a standard curve 
constructed with kaleidoscope marker in SDS-PAGE. Experi-
ments were reproduced several times on independent cell cul-
tures or animals as indicated in the legend of fi gures; results 
exhibit one case in point from the indicated number of 
experiments. 
 Statistics 
 Data were analyzed using the R software ( 22 ). For each  Fads 
transcript level, a linear model was applied on data to estimate 
the effect of sex and tissue as well as their interaction. 
 RESULTS 
 Expression of the  Fads genes in rat tissues 
 The expression of the  Fads3 gene was estimated by de-
termining the tissue distribution of  Fads3 transcripts as 
compared with the other genes of the cluster ( Fig. 2 ). 
First, this experiment underlined a high signifi cant effect 
of sex, tissue, and the interaction of sex and tissue on the 
mRNA level of each  Fads gene ( P  < 10 5 ). Second, our results 
showed that in somatic tissues,  Fads1 and  Fads2 displayed 
a similar mRNA profi le ( Fig. 2A, B) with the highest 
transcript amounts in the liver, kidney, brain, lung, and 
aorta.  Fads3 mRNAs were differently distributed and 
mainly present in the lung, white AT, aorta, spleen, heart, 
and kidney ( Fig. 2C ). The pancreas and skeletal and ab-
dominal muscles shared the lowest transcript level of  Fads 
whereas the aorta, lung, and kidney represented tissues 
with the highest transcript level commonly found for each 
 Fads gene. Moreover, our data showed a differential  Fads 
mRNA amount according to gender. For instance,  Fads3 
transcripts were signifi cantly more abundant in females 
than in males, particularly in the aorta, brown AT, and 
skeletal and abdominal muscles. In sexual organs,  Fads2 
mRNA and, to a lesser extent,  Fads1 mRNA were highly 
abundant especially in testis whereas  Fads3 mRNA was not 
particularly represented. These data demonstrated that 
 Fads3 transcripts, as well as  Fads1 and  Fads2 transcripts, 
were distributed in a tissue-specifi c and sex-dependent 
manner. 
 TABLE 1. Primers and TaqMan probes used for quantifi cation of the  Fads mRNA levels determined 
by real-time PCR 
Forward Primer (5 ′ -3 ′ ) Reverse Primer (5 ′ -3 ′ ) 5 ′ -FAM/TAMRA-3 ′ Probe
 Fads1 agctttgaacccaccaagaataag cagcaggatgtgcagcagatag ttccgggagctgcgggcc
 Fads2 tccacaaggaccccgacata ttgtagggcagatatttcagcttctt ttggagagtggcagcccctcgagta
 Fads3 tgctgtgggctgccagtt caccctgacagcaacgaaga ccccttctatggtgccactgggacac
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shown). In sexual organs, the major protein was detected 
at 37 kDa in the ovary ( Fig. 4B ). The 51 kDa protein was 
equivalently present in all tissues except in the prostate, 
whereas no protein was observed at 75 kDa. 
 This data showed three potential protein isoforms of 
FADS3, one of which was expected at 51 kDa. When tissues 
were presented in the decreasing order of the mRNA level 
determined in  Fig. 2C , we showed that the occurrence of 
FADS3 was independent of the transcription level. Thus, 
our results have demonstrated that the  Fads3 mRNA level 
is not correlated with the FADS3 protein level. 
 We further investigated these three isoforms of FADS3 
in native PAGE by focusing on the lung, heart, kidney, and 
skeletal muscle ( Fig. 4C ). When the 51 kDa and 75 kDa 
isoforms from the lung, heart, and kidney were studied in 
native conditions, two bands were observed. On the con-
trary, the 37 kDa isoform from skeletal muscle migrated as 
a single band. 
 Occurrence of FADS3 in mouse tissues 
 The expression of FADS3 was also tested on several tis-
sue extracts from mice using our two rat FADS3 antibodies 
( Fig. 5 ). Our results showed a similar profi le with three 
protein isoforms. The 75 kDa protein was only observed in 
the lung. Liver and kidney presented the 51 kDa protein 
together with the 37 kDa protein, which is particularly 
abundant as compared with the rat tissues ( Fig. 4A ). Heart 
only contained the 51 kDa protein at a very low level and 
no 37 kDa protein as anticipated. The most unexpected 
result appeared in skeletal muscle, which displayed no 
protein, whereas it corresponded to the main tissue ex-
pressing the 37 kDa protein in rat. Thus, these results con-
fi rmed the presence of three isoforms of FADS3 distributed 
differently according to the tissues and depending on the 
animal type. 
 Occurrence of FADS3 in human cells and tissues 
 We then studied the natural FADS3 protein on human 
cells (SH-SY5Y and HUH7) and tissues using both anti-
NtermFADS3 and anti-CtermFADS3 ( Fig. 6 ) . The target 
peptides designed to produce these antibodies share 85% 
 Fig.  2. Transcript level of  Fads in rat tissues. Total RNA was ex-
tracted from male and female rat tissues, retrotranscripted, and 
quantifi ed by TaqMan® real-time PCR as described in Methods. 
Somatic and germinal tissues were then ordered according to the 
relative expression for each  Fads gene. A: Transcript level of  Fads1 . 
B: Transcript level of  Fads2 . C: Transcript level of  Fads3 . Data are 
presented as the mean ± SEM of separate experiments on three 
rats with four measurements per animal. sk. muscle, skeletal mus-
cle; abdo. muscle, abdominal muscle; AT, adipose tissue; seminal 
ves., seminal vesicle. 
 Fig.  3. Rat FADS3 antibody characterization. To characterize the 
immunospecifi city, antibodies were tested on rat recombinant 
FADS1, FADS2, and FADS3. Cos-7 cells were transfected with pCMV, 
pCMV/ Fads1 , pCMV/ Fads2 , or pCMV/ Fads3 plasmids. Western 
blots were assessed on cell extracts containing recombinant FADS 
proteins. One polyclonal antibody detected both FADS2 and 
FADS3 and was referred to as anti-FADS2/3. Two purifi ed poly-
clonal antibodies detected specifi cally FADS3 and were referred to 
as anti-NtermFADS3 and anti-Cterm-FADS3. Experiments were re-
produced three times; results exhibit only one case in point. 
 by guest, on M
arch 6, 2013
w
w
w
.jlr.org
D
ow
nloaded from
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ously exhibited in various human tissues. Marquardt et al. 
( 6 ) showed, by Northern blot, a consistent level of  FADS3 
transcripts in the heart, brainstem, and liver as compared 
with the uterus and lung. We did not obtain the same re-
sult in rat using real-time PCR. First, we found the highest 
transcription level of  Fads3 particularly in the lung but also 
in the heart. Our result was confi rmed by Northern blot 
(data not shown). Second, the most unexpected result lies 
in the fact that the level of  Fads3 mRNA is weak in the liver, 
which is considered the main organ of FA desaturases such 
as  Fads1 and  Fads2 ( 5, 23, 24 ). Moreover, the  Fads3 mRNA 
profi le in rat tissues was different from those determined 
for  Fads1 and  Fads2 suggesting a differential function of 
 Fads3 in lipid metabolism. 
 Thereafter, taking the translation into consideration, 
we further investigated the expression of FADS3. We used 
different specifi c antibodies directed against the N-terminal 
and carboxyl-terminal sequences of rat FADS3, corre-
sponding respectively to the cytochrome b5-like domain 
and the FA desaturase domain ( Fig. 1 ). We found three 
potential protein isoforms (37 kDa, 51 kDa, and 75 kDa) 
differently distributed according to the species (rat and 
mouse). The 51 kDa molecular mass corresponds to the 
predicted size of murine FADS3 considering the cDNA se-
and 100% homology with the human protein sequence, 
respectively; therefore, these antibodies conceived to de-
tect the rat FADS3 protein can also interact with the hu-
man one. 
 Our results on human cells showed different isoforms of 
FADS3 detected with the anti-CtermFADS3 antibody ( Fig. 
6A ). In SH-SY5Y cells, we found three proteins with appar-
ent molecular masses of 61 kDa, 56 kDa, and 37 kDa. The 
37 kDa isoform was previously found in rat and mouse tis-
sues in comparison with the two other proteins. The 61 
kDa isoform was a protein commonly found in SH-SY5Y 
and HUH7 cells and commonly detected with both anti-
NtermFADS3 and anti-CtermFADS3 (data not shown). 
 In human tissues, fi rst, we found the same 56 kDa iso-
form located ubiquitously and also another slightly heavier 
one at 59 kDa, but only in the lung, kidney, brain, and 
skeletal muscles ( Fig. 6B ). Second, the 37 kDa isoform and 
a second one, just above at 39 kDa, were also detected in 
the same tissues as observed in rat ( Fig. 4A ). Pancreas did 
not display any of these isoforms as previously observed in 
rat, whereas kidney presented both isoforms undetected 
in rat. Third, the 75 kDa isoform especially present in the 
rat lung was not observed in the human lung with the anti-
NtermFADS3 (data not shown) but this antibody revealed 
a new isoform of FADS3 at 28 kDa, mainly in the lung, 
kidney, pancreas, and ovary and to a lesser extent in the 
brain and liver. 
 These results together showed that FADS3 is expressed 
in human cultured cells and tissues under different iso-
forms commonly found in the murine tissues or specifi c to 
humans. 
 DISCUSSION 
 This study presented the cloning of  Fads3 and, for the 
fi rst time, the occurrence of the natural FADS3 protein in 
mammalian tissues or cells, which demonstrated that  Fads3 
is not a pseudogene. 
 The analysis of rat tissues confi rmed that  Fads3 is tran-
scripted in an organ-specifi c manner. This data was previ-
 Fig.  4. FADS3 distribution in rat tissues. The occur-
rence of FADS3 was determined in different rat tissues. 
SDS-PAGE (A and B) and native PAGE (C) were per-
formed on protein lysates from somatic male tissues (A) 
and from male and female germinal tissues (B). West-
ern blots were then assessed using rat anti-FADS3 
antibodies ( 1 anti-NtermFADS3 and  2 anti-CtermFADS3). 
The intensity of band observed in abdominal and skel-
etal muscles was deliberately reduced by fi ve because of 
the excessive signal. Experiments were reproduced on 
three rats; results exhibit only one case in point. 
 Fig.  5. FADS3 occurrence in mouse tissues. The FADS3 profi le 
was determined on mice. SDS-PAGE was performed on protein 
lysates from female mouse tissues. FADS3 was then detected by 
Western blot with rat anti-FADS3 antibodies ( 1 anti-NtermFADS3 
and  2 anti-CtermFADS3). Experiments were reproduced on three 
mice; results exhibit only one case in point. 
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it would correspond to the putative FA desaturase domain. 
This short molecular mass could be explained by protein 
degradation or cleavage; one is known in the  169 VLA•AL 
motif, which separates the cytochrome b5-like domain 
from the FA desaturase domain, but that cleavage would 
generate a 33 kDa protein. We can also hypothesize the 
possibility of an alternative translation initiation process. 
In that case, a 37.3 kDa fragment would be produced if the 
translation is initiated by the second  129 Met found in the 
primary sequence of FADS3, even though the sequence 
conditions of such a process do not appear optimal here 
( 26 ). Such a 37 kDa size was also observed for the   9-
desaturase from rat liver using antibodies against C termi-
nus of rat SCD1 and SCD2 ( 27 ). Thus, the 37 kDa protein 
could present the same structure as the purifi ed   9-
desaturase naturally devoid of fused cytochrome b5-like 
domain. 
 The three potential isoforms of FADS3 identifi ed in rat 
were also detected in mouse using the same rat FADS3 an-
tibodies. The tissue distribution was, nevertheless, differ-
ent notably in muscles where no 37 kDa protein was 
observed in mouse tissues as compared with rat tissues. 
This unexpected result could be explained by the fact that 
the experiment was conducted on female mice. Indeed, 
we previously showed a signifi cant difference between 
male and female rats on the transcript level of  Fads3 espe-
cially in skeletal muscles. To confi rm this distinction be-
tween genders, we looked at the occurrence of the 37 kDa 
protein in rat tissues and specifi cally in skeletal muscles 
but no difference was observed (data not shown). Thus, 
FADS3 is thought to be located variably depending not 
only on the tissues but also on the murine species or 
strains. This may be extended to humans, as demonstrated 
in our results on human cultured cells where we also iden-
tifi ed various isoforms of FADS3 differently distributed 
according to the cell types (neuroblastoma and hepa-
toma cells) collected from males (HUH7) or females 
(SH-SY5Y). 
 The tissue distribution of FADS3 was also tested on hu-
man samples and our results underlined the presence of 
multiple isoforms of the natural protein. We did not ob-
serve the predicted protein at 51 kDa but two heavier ones, 
which molecular mass probably results from a posttransla-
tional modifi cation. The most unexpected result came 
from the new isoform at 28 kDa only detected with the 
anti-NtermFADS3 antibody. This short isoform corre-
sponds to the N-terminal end of FADS3 containing the 
cytochrome b5-like domain. No explanation can be postu-
lated on the nature of such a size with regard to the known 
putative cleavage sites, but this may be the product of an 
alternative transcript with truncated and skipped exons as 
described by Park et al. ( 13 ). This isoform would be, thus, 
an enzymatic cofactor or a short protein involved in the 
regulation of the FA metabolism. 
 Alternately, if different natural isoforms of FADS3 were 
present in humans, these results obtained on a commer-
cial tissue blot have nevertheless to be considered as the 
result on one sample of one human being. Further experi-
ments have to be investigated to confi rm these results from 
quence. When studied in rats, this 51 kDa protein was es-
sentially present in the liver contrary to the transcript level. 
The data also observed for the other tissues suggest that 
no correlation exists between the transcription level and 
the translation rate of  Fads3 . More than the mRNA amount, 
the occurrence of FADS3 in liver is consistent with the 
idea that this protein may be an FA desaturase as invoked 
by its amino acid sequence. 
 A 75 kDa protein was also present but merely in a few 
tissues (present in 24% of all organs as compared with 
62% for the 51 kDa protein). This occurred only by using 
the anti-NtermFADS3 antibody but not with the anti-
CtermFADS3 antibody, which suggests that the 75 kDa 
protein would be devoid of the C-terminal end containing 
an FA desaturase domain ( Fig. 1B ). In that case, this sugges-
tion is singular considering a potential desaturase activity 
of FADS3. Moreover, the unexpected size could result 
from a cleavage of FADS3 and a subsequent fusion form-
ing a new protein complex. We can hypothesize that this 
posttranslational modifi cation may confer a new function 
or a different subcellular targeting to the protein. Such a 
situation was observed, for instance, on p21-activated pro-
tein kinase 2, which is cleaved by a caspase and then 
myristoylated, redirecting the mature protein from the 
cytosol to the plasma membrane and thus, promoting 
cell death ( 25 ). 
 In native PAGE, the 51 kDa and 75 kDa proteins were 
detected as oligomers or protein complexes, contrary to 
the 37 kDa protein found as a single protein. That addi-
tional information on native proteins argues in favor of a 
different physiological involvement of FADS3 depending 
on the isoform. The 37 kDa protein was detected in mam-
malian tissues with only the anti-CtermFADS3, suggesting 
 Fig.  6. FADS3 occurrence in human cells and tissues. The occur-
rence of natural FADS3 was studied in different human cells and 
tissues. FADS3 was detected by Western blot with rat anti-FADS3 
antibodies ( 1 anti-NtermFADS3 or  2 anti-CtermFADS3). A: FADS3 
was determined in neuroblastoma SH-SY5Y cells and hepatoma 
HUH7 cells in the exponential growth phase. Experiments were 
reproduced on three independent cell cultures; results exhibit 
only one case in point. B: The tissue distribution of FADS3 was 
performed on a commercial human tissue blot. Experiments were 
representative of one sample of one human tissue. 
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independent human samples taking into account the het-
erogeneity of a population. 
 To conclude, FADS3 does exist. In this study, we re-
ported the occurrence of different potential isoforms of 
FADS3 in rat, mouse, and human tissues. The demonstra-
tion of multiple  Fads3 gene products was not unexpected 
with regard to Park’s results on alternative transcripts of 
 FADS3 expressed in baboon tissues, even if we did not fi nd 
nine proteins ( 13 ). If FADS3 is ubiquitously expressed in 
the organism, its biological function remains unknown. 
Our preliminary experiments carried out on pCMV- Fads3 
transfected Cos-7 and SH-SY5Y cells did not result in a 
change of the lipid pattern. Our fi ndings on the protein 
profi le exposed in this article have now to be considered 
for further investigations on the physiological role of 
FADS3, as an enzyme as predicted by its structure or maybe 
as a regulation protein in the FA metabolism.  
 We thank the Région Bretagne, the Groupe Lipides et Nutrition, 
Valorex (Combourtillé, France), and Polaris (Pleuven, France) 
for their fi nancial support. 
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